The 21st meeting of the Biopharmaceutical Applied Statistics Symposium (BASS XXI) will be held November 3–7 at the Crowne Plaza Washington DC-Rockville. At least 16 one-hour tutorials on diverse topics pertinent to the research, clinical development, and regulation of pharmaceuticals will be presented November 3–5 by speakers from academia, the pharmaceutical industry, and the Food and Drug Administration (FDA). Two parallel two-day short courses will be presented November 6–7.
Popular features of BASS XXI are the keynote address on November 4, with reception following, and the November 5 FDA Biometrics session.
BASS is a nonprofit entity established for the purpose of fundraising to support graduate studies in biostatistics. To date, BASS has provided support to more than 50 master’s or doctoral degree graduate students in biostatistics.
For further information, visit the conference website or contact the BASS registrar at Rewhitworth@gmail.com, Andreas Sashegyi at (317) 532-7414 or aisasheg@lilly.com, or Karl Peace at (912) 681-6980 or peacekarl@frontier.com.
Leave a Reply